I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Arak, Haci
18
results:
Search for persons
X
Format
Online (18)
Mediatypes
Articles (Online) (5)
OpenAccess-fulltext (13)
Sorted by: Relevance
Sorted by: Year
?
1
Prognostic significance of 68 Ga-FAPI PET/CT in patients wi..:
Arak, Hacı
;
Elboga, Umut
;
Cayirli, Yusuf Burak
.
Annals of Nuclear Medicine. 38 (2024) 8 - p. 630-638 , 2024
Link:
https://doi.org/10.1007/..
?
2
Prognostic and Predictive Significance of HER2-low Expressi..:
Arak, Hacı
;
Kuş, Tülay
European Journal of Therapeutics. , 2024
Link:
https://doi.org/10.58600..
?
3
The effect of examining somatic alterations with NGS in pat..:
Arak, Hacı
;
Sahinoğlu, Bahtiyar
;
KUS, Tulay
Journal of Oncology Pharmacy Practice. , 2024
Link:
https://doi.org/10.1177/..
?
4
The real‐world outcomes of Lutetium‐177 PSMA‐617 radioligan..:
Almuradova, Elvina
;
Seyyar, Mustafa
;
Arak, Hacı
...
International Journal of Cancer. 154 (2023) 4 - p. 692-700 , 2023
Link:
https://doi.org/10.1002/..
?
5
The percentage of ALK-positive cells and the efficacy of fi..:
Hizal, Mutlu
;
Bilgin, Burak
;
Paksoy, Nail
...
Journal of Cancer Research and Clinical Oncology. 149 (2022) 8 - p. 4141-4148 , 2022
Link:
https://doi.org/10.1007/..
?
6
Efficacy of Capecitabine and Temozolomide Regimen in Neuroe..:
Karabulut, Senem
;
Tastekin, Didem
;
AKYILDIZ, ARİF
...
7e9bc086-d849-4244-94fe-260d1b54df39. , 2023
Link:
https://doi.org/10.1093/..
?
7
Real-life experience of patients with sarcomatoid renal cel..:
Arak, Haci
;
Gokmen, Ivo
;
PAYDAŞ, SEMRA
...
48a26046-e057-4787-b78c-518c316f9208. , 2023
Link:
https://doi.org/10.4149/..
?
8
Real-life comparison of afatinib and erlotinib in non-small..:
Ozturk, Akin
;
Kut, Engin
;
Turkoz, Fatma Paksoy
...
c0a975c2-802d-4b32-814b-0f6fdae9e498. , 2023
Link:
https://doi.org/10.1007/..
?
9
Efficacy of Capecitabine and Temozolomide Regimen in Neuroe..:
Ercelep, Özlem
;
YALÇIN, ŞUAYİB
;
YAŞAR, SERKAN
...
7e9bc086-d849-4244-94fe-260d1b54df39. , 2023
Link:
https://doi.org/10.1093/..
?
10
The percentage of ALK-positive cells and the efficacy of fi..:
Aydiner, Adnan
;
Ayhan, Murat
;
KESKİNKILIÇ, MERVE
...
c660c78b-2ee2-43de-ab96-b732abd5a4c2. , 2023
Link:
https://doi.org/10.1007/..
?
11
Assessing the Clinical Impact of Lutetium-177 DOTATATE Pept..:
Dursun, Bengu
;
Arak, Haci
;
On, Sercan
...
49b5bdea-b5d9-485e-a0bd-776bcbf457e3. , 2023
Link:
https://doi.org/10.14744..
?
12
Real-life comparison of afatinib and erlotinib in non-small..:
Selcukbiricik, Fatih
;
Turkoz, Fatma Paksoy
;
Gursoy, Pinar
...
Journal Of Cancer Research And Clinical Oncology. , 2022
Link:
https://hdl.handle.net/1..
?
13
Real-life comparison of afatinib and erlotinib in non-small..:
Akangunduz, Baran
;
Ozturk, Akin
;
Cavdar, Eyyup
...
http://hdl.handle.net/20.500.12645/30548. , 2022
Link:
https://hdl.handle.net/2..
?
14
Prognostic factors of perioperative FLOT regimen in operabl..:
Türker, Sema
;
Yalçin, Şuayib
;
YILDIRIM, HASAN ÇAĞRI
...
5b1dfa63-e49a-4d8e-b30c-0f57cbc15d5d. , 2022
Link:
https://doi.org/10.55730..
?
15
Real-life comparison of afatinib and erlotinib in non-small..:
Arak, Haci
;
Yumuk, Perran Fulden
;
NART, DENİZ
...
c0a975c2-802d-4b32-814b-0f6fdae9e498. , 2022
Link:
https://doi.org/10.1007/..
1-15